Overview
Subscribe
VC Statistics
Back to VC Home
MedTRACK
MedTRACK Japan
Report Center

 
Venture Finance Statistics

Our Venture Finance Database, which includes many of the Life Science Venture Financing transactions over the last fifteen years, is updated on a daily basis. We rely on annual reports, regulatory filings, press releases, articles, websites and company contacts to source this information. Venture finance is subject to timing and we combine the most up-to-date information with the ability to gain a historical perspective by searching the database. We have summarized Venture Financing Rounds for your convenience and will continue to update them as our database expands.

Top 15 Investment Firms in 2009 based on Rounds of Financing
Firm NameRoundsCapital Amount
(USD Millions)
Novartis Venture Funds21--
Kleiner Perkins Caufield & Byers202700
New Enterprise Associates, Inc. (NEA)20--
Polaris Venture Partners203000
Versant Venture Management LLC191600
SV Life Sciences (formerly Schroder Ventures Life Sciences)181500
Domain Associates, L.L.C.172500
Novo A/S16--
Texas Coalition for Capital16--
InterWest Partners LLC152800
MPM Capital152000
Abingworth Management Limited141250
GrowthWorks Capital, Ltd.14655
Johnson & Johnson Development Corporation (venture arm of Johnson & Johnson)14--
Pittsburgh Life Sciences Greenhouse14--

Top 15 Investment Raised Companies during 2009
Company NameAmount Raised
(USD Millions)
Crucell N.V.443.52
Clovis Oncology, Inc.145
Intercell AG123.5
Small Bone Innovations, Inc.73
Amarin Corporation plc70
Pacific Biosciences, Inc.68
Hyperion Therapeutics, Inc.60
Sopherion Therapeutics, Inc.55
TransEnterix55
NovImmune SA54.8
Probiodrug AG53
Anacor Pharmaceuticals, Inc.50
PTC Therapeutics, Inc.50
Xanodyne Pharmaceuticals, Inc. (formerly Xanodyne Pharmacal)50
Calypso Medical Technologies, Inc.50





 
 
Current Statistics
Total Transactions13088
Total Companies5420
Total Firms5736

800 James Ave.
Suite 201
Scranton, PA 18510

If you would like immediate response, you may contact directly.
Telephone:
570-504-1800
email: info@medtrack.com



 
The information contained herein is based on sources believed to be reliable but is neither all-inclusive nor guaranteed by Life Science Analytics ("LSA"). Opinions, if any, reflect the judgment of LSA at this time and are subject to change. LSA does not undertake to advise you of changes in their opinion or information. Most of the companies LSA follows are emerging growth companies whose securities typically involve a higher degree of risk and more volatility than the securities of more established companies. The securities discussed in the reports included in LSA's Database may be unsuitable for investors depending on their specific investment objectives, financial situation and needs. No report included in the LSA Database is a recommendation that any particular investor should purchase or sell any particular security in any amount or at all, and is not a solicitation of any offer to purchase or sell from or to any particular investor. For additional information that may be available on the securities mentioned, please contact Life Science Analytics.